NitroMed Looks To 2010 NDA For BiDil XR

Firm decides to slash jobs, quit promotion of immediate-release BiDil to fund development and commercialization of extended-release version.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet